We report here data demonstrating that individuals with NAFLD, who have an increase in erythrocyte DHA enrichment of ⩾2% (as a marker of tissue enrichment25, 26) through treatment with omega-3 FA, show favourable changes in both hepatic insulin sensitivity and hepatic FA metabolism. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.